Misplaced Pages

COVID-19 vaccination in Egypt

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Plan to immunize against COVID-19 See also: COVID-19 pandemic in Egypt

COVID-19 vaccination in Egypt
Date24 January 2021 - present
LocationEgypt
CauseCOVID-19 pandemic
MotiveCOVID-19 pandemic in Egypt

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

History

Timeline

Egypt began its vaccination program on 24 January 2021. Egypt received 50,000 doses of the Sinopharm BIBP vaccine on 10 December 2020, followed by 50,000 doses of the AstraZeneca vaccine on 31 January 2021. In February, March and May 2021, Egypt received 1.1 million doses of the Sinopharm BIBP vaccine and 2.55 million doses of the Oxford–AstraZeneca vaccine.

On 6 August 2021, Romania announced its intention to donate 525,000 doses of the Oxford-AstraZeneca vaccine to Egypt.

In October 2021, the United States delivered 8.25 million doses of the Pfizer-BioNTech vaccine to Egypt through COVAX.

On 25 December 2021, the United States delivered a further shipment of 1.5 million doses of the Pfizer-BioNTech vaccine via COVAX.

On 30 December 2021, Egypt received 347,460 doses of the Oxford-AstraZeneca vaccine through COVAX.

By the end of 2021, more than 55 million vaccine doses had been administered.

On 1 January 2022, Egypt received 1.5 million doses of the Pfizer-BioNTech vaccine donated by the United States.

Progress

1,315 vaccine doses had been administered by the end of February 2021; 78,879 doses by the end of March; 928,930 by the end of April; 2,586,274 by the end of May; 4,282,641 by the end of June; 5,337,506 by the end of July; 8,741,005 by the end of August; 13.8 million by the end of September; 25.1 million by the end of October; 37.7 million by the end of November; 53.7 million by the end of December 2021; 65.1 million by the end of January 2022; 71.4 million by the end of February 2022; 78 million by the end of March 2022; 82 million by the end of April 2022. 49% of the targeted population had been fully vaccinated by the end of 2021.

Cumulative vaccinations in Egypt

Graphs are unavailable due to technical issues. Updates on reimplementing the Graph extension, which will be known as the Chart extension, can be found on Phabricator and on MediaWiki.org.

See also

References

  1. El Sharkawy, Lamis (27 February 2021). "Egypt's coronavirus vaccination campaign: A timeline". Ahram online. Archived from the original on 12 May 2021. Retrieved 12 May 2021.
  2. "WHO EMRO | Egypt receives second shipment of 1.77 million COVID-19 vaccines through the COVAX Facility | News | Media centre". www.emro.who.int. Archived from the original on 12 July 2021. Retrieved 12 July 2021.
  3. "owid/covid-19-data". GitHub. Archived from the original on 22 June 2021. Retrieved 12 July 2021.
  4. AfricaNews (29 June 2021). "Egypt: Haphazard and flawed Covid-19 vaccine rollout fails to prioritize most at-risk". Africanews. Archived from the original on 12 July 2021. Retrieved 12 July 2021.
  5. "Romania to donate 1.3 million doses of anti-Covid vaccine to Tunisia, Egypt, Albania and Vietnam". Archived from the original on 7 August 2021. Retrieved 22 August 2021.
  6. "Egypt receives 1.5 million doses of coronavirus Pfizer vaccine from US - Health - Egypt". Ahram Online. Archived from the original on 26 December 2021. Retrieved 26 December 2021.
  7. ^ "Egypt receives additional 1.5 million doses of Pfizer-BioNTech COVID-19 vaccine from US". Egypt Today. 2 January 2022. Archived from the original on 5 January 2022. Retrieved 5 January 2022.
  8. "owid/covid-19-data". GitHub. Archived from the original on 22 June 2021. Retrieved 7 March 2021.
COVID-19 pandemic
Timeline
Pre-pandemic
2020
2021
2022
2023
Locations
Africa
Northern
Eastern
Southern
Central
Western
Asia
Central/North
East
Mainland China
South
India
By location
Southeast
Malaysia
Philippines
West
Europe
United Kingdom
By location
Eastern
Western Balkans
European Union
EFTA countries
Microstates
North
America
Atlantic
Canada
Caribbean
Countries
British Overseas Territories
Caribbean Netherlands
French West Indies
US insular areas
Central America
United States
responses
By location
Oceania
Australia
New Zealand
South
America
Others
Impact
Culture and
entertainment
Arts and
cultural heritage
Education
By country
Sports
By country
By sport
Society
and rights
Social impact
Labor
Human rights
Legal
Minority
Religion
Economic
By country
By industry
Supply and trade
Financial markets
Information
Misinformation
Politics
Political impact
Protests
International relations
Language
Others
Health issues
Medical topics
Testing and
epidemiology
Apps
Prevention
Vaccines
Topics
Authorized
DNA
Inactivated
mRNA
Subunit
Viral vector
Virus-like particles
In trials
Attenuated
DNA
Inactivated
RNA
Subunit
Viral vector
Virus-like particles
Deployment
by location
Africa
Asia
Europe
North America
Oceania
South America
Others
Treatment
Monoclonal antibodies
Small molecule antivirals
Variants
Specific
General
Institutions
Hospitals and
medical clinics
Mainland China
Others
Organizations
Health
institutes
Pandemic
institutes
Relief funds
People
Medical
professionals
Researchers
Officials
WHO
By location
Others
List of deaths due to COVID-19
Data (templates)
Global
Africa
Americas
Asia
Europe
Oceania
Others
COVID-19 vaccination in Africa
Sovereign states
States with limited
recognition
Dependencies and
other territories


Stub icon

This article about COVID-19 vaccines is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This Egypt-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: